Bulk Manufacturer of Controlled Substances Application: Alltech Associates, Inc., 27936-27937 [2014-11137]
Download as PDF
27936
Federal Register / Vol. 79, No. 94 / Thursday, May 15, 2014 / Notices
Office of Diversion Control, Drug
Enforcement Administration, that the
requirements for such registration
pursuant to 21 U.S.C. 958(a); 21 U.S.C.
823(a); and 21 CFR 1301.34(b), (c), (d),
(e), and (f) are satisfied.
Dated: May 1, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2014–11240 Filed 5–14–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been re-delegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR part 0,
subpart R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on
November 26, 2013, Siemens Healthcare
Diagnostics, Inc., Attn: RA, 100 GBC
Drive, Mail Stop 514, Newark, Delaware
19702, applied to be registered as a bulk
manufacturer of the following basic
classes of narcotic or non-narcotic
controlled substances:
Drug Enforcement Administration
Controlled substance
[Docket No. DEA–392]
Tetrahydrocannabinols (7370) .....
Ecgonine (9180) ...........................
Morphine (9300) ...........................
Bulk Manufacturer of Controlled
Substances Application: SIEMENS
Healthcare Diagnostics, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before July 14, 2014.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
DATES:
Schedule
I
II
II
The company plans to produce the
listed controlled substances in bulk to
be used in the manufacture of reagents
and drug calibrator controls which are
DEA exempt products.
In reference to drug code 7370 the
company plans to bulk manufacture a
synthetic tetrahydrocannabinol. No
other activity for this drug code is
authorized for this registration.
Dated: May 2, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–11112 Filed 5–14–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before July 14, 2014.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been re-delegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR part 0,
subpart R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on March
17, 2014, Alltech Associates, Inc., 2051
Waukegan Road, Deerfield, Illinois
60015, applied to be registered as a bulk
manufacturer of the following basic
classes of narcotic or non-narcotic
controlled substances:
SUPPLEMENTARY INFORMATION:
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Alltech
Associates, Inc.
ACTION:
Notice of application.
TKELLEY on DSK3SPTVN1PROD with NOTICES
Controlled substance
Schedule
Methcathinone (1237) ..................................................................................................................................................................................
N-Ethylamphetamine (1475) ........................................................................................................................................................................
N,N-Dimethylamphetamine (1480) ..............................................................................................................................................................
4-Methylaminorex (cis isomer) (1590) .........................................................................................................................................................
Gamma Hydroxybutyric Acid (2010) ...........................................................................................................................................................
Alpha-ethyltryptamine (7249) ......................................................................................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
2C-T-7 (2,5-Dimethoxy-4-(n)- ......................................................................................................................................................................
propylthiophenethylamine) (7348) ...............................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
Mescaline (7381) .........................................................................................................................................................................................
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl)ethanamine) (7385) ...............................................................................................................
4-Bromo-2,5-dimethoxyamphetamine (7391) ..............................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine (7392) ..........................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine (7395) ..............................................................................................................................................
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................
VerDate Mar<15>2010
18:18 May 14, 2014
Jkt 232001
PO 00000
Frm 00100
Fmt 4703
Sfmt 4703
E:\FR\FM\15MYN1.SGM
15MYN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
27937
Federal Register / Vol. 79, No. 94 / Thursday, May 15, 2014 / Notices
Controlled substance
Schedule
2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................
3,4-Methylenedioxyamphetamine (7400) ....................................................................................................................................................
N-Hydroxy-3,4-methylenedioxyam-phetamine (7402) .................................................................................................................................
3,4-Methylenedioxy-N-ethylam-phetamine (7404) ......................................................................................................................................
3,4-Methylenedioxymetham-phetamine (7405) ...........................................................................................................................................
4-Methoxyamphetamine (7411) ...................................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine (7431) .................................................................................................................................................
Alpha-methyltryptamine (7432) ...................................................................................................................................................................
Bufotenine (7433) ........................................................................................................................................................................................
Diethyltryptamine (7434) .............................................................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
Psilocybin (7437) .........................................................................................................................................................................................
Psilocyn (7438) ............................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine (7439) ..............................................................................................................................................
N-Ethyl-1-phenylcyclohexylamine (7455) ....................................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine (7458) ....................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ...............................................................................................................................................
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine) (7509) .......................................................................................................................
2C-H (2-(2,5-Dimethoxyphenyl)ethanamine) (7517) ...................................................................................................................................
2C-1(2-(4-lodo-2,5-dimethoxyphenyl)ethanamine) (7518) ..........................................................................................................................
2C-C (2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (7519) ......................................................................................................................
2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl)ethanamine) (7532) .......................................................................................................
Dihydromorphine (9145) ..............................................................................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
1-Phenylcyclohexylamine (7460) .................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Phenylacetone (8501) .................................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................
Cocaine (9041) ............................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Dihydrocodeine (9120) ................................................................................................................................................................................
Ecgonine (9180) ..........................................................................................................................................................................................
Meperidine intermediate-B (9233) ...............................................................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Noroxymorphone (9668) ..............................................................................................................................................................................
The company plans to manufacture
high purity drug standards used for
analytical applications only in clinical,
toxicological, and forensic laboratories,
and for distribution to its customers.
Dated: May 2, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–11137 Filed 5–14–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Occupational Safety and Health
Administration
Susan Harwood Training Grant
Program, FY 2014
Occupational Safety and Health
Administration (OSHA), Labor.
ACTION: Notice of availability of funds
and solicitations for grant applications
(SGA) for Targeted Topic Training and
Capacity Building grants.
TKELLEY on DSK3SPTVN1PROD with NOTICES
AGENCY:
Funding Opportunity No.: SHTG–FY–
14–01 (Targeted Topic Training grants).
Funding Opportunity No.: SHTG–FY–
14–02 (Capacity Building grants).
VerDate Mar<15>2010
18:18 May 14, 2014
Jkt 232001
Catalog of Federal Domestic
Assistance No.: 17.502.
SUMMARY: This notice announces
availability of approximately $3.5
million for Susan Harwood Training
Program Targeted Topic Training grants
in two categories: Targeted Topic
Training and Targeted Topic Training
and Educational Materials
Development. This notice also
announces availability of approximately
$3.5 million for Susan Harwood
Training Program Capacity Building
grants in two categories: Capacity
Building Developmental and Capacity
Building Pilot.
DATES: Grant applications for Capacity
Building grants must be received
electronically by the Grants.gov system
no later than 11:59 p.m., ET, on
Thursday, June 26, 2014. Grant
applications for Targeted Topic Training
grants must be received electronically
by the Grants.gov system no later than
11:59 p.m., ET, on Monday, June 30,
2014.
The complete Susan
Harwood Training Grant Program
solicitation for grant applications and
all information needed to apply for
ADDRESSES:
PO 00000
Frm 00101
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
these funding opportunities are
available at the Grants.gov Web site,
https://www.grants.gov.
FOR FURTHER INFORMATION CONTACT:
Questions regarding the solicitations for
grant applications should be emailed to
HarwoodGrants@dol.gov or directed to
Heather Wanderski, Program Analyst, or
Jim Barnes, Director, Office of Training
Programs and Administration, at 847–
759–7700 (note this is not a toll-free
number). Personnel will not be available
after 5:00 p.m., ET, on the application
deadline, to answer questions. To obtain
further information on the Susan
Harwood Training Grant Program, visit
the OSHA Web site at: https://
www.osha.gov/dte/sharwood/
index.html.
Questions regarding Grants.gov
should be emailed to Support@
grants.gov or directed to the Grants.gov
Contact Center, at 1–800–518–4726 (toll
free number). The Contact Center is
available 24 hours a day, 7 days a week.
The Contact Center is closed on Federal
holidays.
E:\FR\FM\15MYN1.SGM
15MYN1
Agencies
[Federal Register Volume 79, Number 94 (Thursday, May 15, 2014)]
[Notices]
[Pages 27936-27937]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11137]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Alltech
Associates, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before July 14, 2014.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, and dispensers of controlled substances
(other than final orders in connection with suspension, denial, or
revocation of registration) has been re-delegated to the Deputy
Assistant Administrator of the DEA Office of Diversion Control
(``Deputy Assistant Administrator'') pursuant to sec. 7(g) of 28 CFR
part 0, subpart R, App.
In accordance with 21 CFR 1301.33(a), this is notice that on March
17, 2014, Alltech Associates, Inc., 2051 Waukegan Road, Deerfield,
Illinois 60015, applied to be registered as a bulk manufacturer of the
following basic classes of narcotic or non-narcotic controlled
substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Methcathinone (1237)........................ I
N-Ethylamphetamine (1475)................... I
N,N-Dimethylamphetamine (1480).............. I
4-Methylaminorex (cis isomer) (1590)........ I
Gamma Hydroxybutyric Acid (2010)............ I
Alpha-ethyltryptamine (7249)................ I
Lysergic acid diethylamide (7315)........... I
2C-T-7 (2,5-Dimethoxy-4-(n)-................ I
propylthiophenethylamine) (7348)............ I
Tetrahydrocannabinols (7370)................ I
Mescaline (7381)............................ I
2C-T-2 (2-(4-Ethylthio-2,5- I
dimethoxyphenyl)ethanamine) (7385).
4-Bromo-2,5-dimethoxyamphetamine (7391)..... I
4-Bromo-2,5-dimethoxyphenethylamine (7392).. I
4-Methyl-2,5-dimethoxyamphetamine (7395).... I
2,5-Dimethoxyamphetamine (7396)............. I
[[Page 27937]]
2,5-Dimethoxy-4-ethylamphetamine (7399)..... I
3,4-Methylenedioxyamphetamine (7400)........ I
N-Hydroxy-3,4-methylenedioxyam-phetamine I
(7402).
3,4-Methylenedioxy-N-ethylam-phetamine I
(7404).
3,4-Methylenedioxymetham-phetamine (7405)... I
4-Methoxyamphetamine (7411)................. I
5-Methoxy-N-N-dimethyltryptamine (7431)..... I
Alpha-methyltryptamine (7432)............... I
Bufotenine (7433)........................... I
Diethyltryptamine (7434).................... I
Dimethyltryptamine (7435)................... I
Psilocybin (7437)........................... I
Psilocyn (7438)............................. I
5-Methoxy-N,N-diisopropyltryptamine (7439).. I
N-Ethyl-1-phenylcyclohexylamine (7455)...... I
1-(1-Phenylcyclohexyl)pyrrolidine (7458).... I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) I
2C-E (2-(2,5-Dimethoxy-4- I
ethylphenyl)ethanamine) (7509).
2C-H (2-(2,5-Dimethoxyphenyl)ethanamine) I
(7517).
2C-1(2-(4-lodo-2,5- I
dimethoxyphenyl)ethanamine) (7518).
2C-C (2-(4-Chloro-2,5- I
dimethoxyphenyl)ethanamine (7519).
2C-T-4 (2-(4-Isopropylthio)-2,5- I
dimethoxyphenyl)ethanamine) (7532).
Dihydromorphine (9145)...................... I
Heroin (9200)............................... I
Normorphine (9313).......................... I
Methamphetamine (1105)...................... II
1-Phenylcyclohexylamine (7460).............. II
Phencyclidine (7471)........................ II
Phenylacetone (8501)........................ II
1-Piperidinocyclohexanecarbonitrile (8603).. II
Cocaine (9041).............................. II
Codeine (9050).............................. II
Dihydrocodeine (9120)....................... II
Ecgonine (9180)............................. II
Meperidine intermediate-B (9233)............ II
Morphine (9300)............................. II
Noroxymorphone (9668)....................... II
------------------------------------------------------------------------
The company plans to manufacture high purity drug standards used
for analytical applications only in clinical, toxicological, and
forensic laboratories, and for distribution to its customers.
Dated: May 2, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-11137 Filed 5-14-14; 8:45 am]
BILLING CODE 4410-09-P